HWEL /
Starton
HWEL to combine with Starton Therapeutics, Inc.
What happened
HWEL entered into a business combination agreement involving Starton Therapeutics, Inc. The agreement provides for $260.0 million in aggregate base consideration, subject to adjustments.
The transaction remains subject to conditions, including approval by HWEL stockholders.
The source
Everything on this page comes from the source below.
HWEL to combine with Starton Therapeutics, Inc.
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly